The Potential Therapeutic Targets of Anlotinib in Osteosarcoma: Characterization Based on Patient‐Derived Xenografts and Next‐Generation Sequencing

MLA

Zuoyao Long, et al. “The Potential Therapeutic Targets of Anlotinib in Osteosarcoma: Characterization Based on Patient‐Derived Xenografts and Next‐Generation Sequencing.” Cancer Medicine, vol. 13, no. 23, Dec. 2024. EBSCOhost, https://doi.org/10.1002/cam4.70416.

APA

Zuoyao Long, Yajie Lu, Minghui Li, Jing Li, Guojing Chen, Fengwei Wang, Qi Wang, Liangbi Xiang, & Zhen Wang. (2024). The Potential Therapeutic Targets of Anlotinib in Osteosarcoma: Characterization Based on Patient‐Derived Xenografts and Next‐Generation Sequencing. Cancer Medicine, 13(23). https://doi.org/10.1002/cam4.70416

Chicago

Zuoyao Long, Yajie Lu, Minghui Li, Jing Li, Guojing Chen, Fengwei Wang, Qi Wang, Liangbi Xiang, and Zhen Wang. 2024. “The Potential Therapeutic Targets of Anlotinib in Osteosarcoma: Characterization Based on Patient‐Derived Xenografts and Next‐Generation Sequencing.” Cancer Medicine 13 (23). doi:10.1002/cam4.70416.